Pivotal Point Tracking Option Care Health (OPCH): Home Infusion Therapy Provider Impresses with $1 Billion Stock Buyback and Strong Outlook!
Reading Time: 1 minute
The company is the largest independent provider of outpatient and home infusion therapies in the USA. On January 13, 2026, strong preliminary business figures and a massive expansion of the stock buyback program triggered a surge in the stock price, catapulting it up by over 8%. Option Care Health expects revenue of up to $1.47 billion for the fourth quarter of 2025 and adjusted EBITDA between $123.7 million and $127.7 million. The Board also doubled the buyback program to $1 billion, underscoring confidence in long-term cash flow generation. Option...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
